Prof. Mohit Kapoor

Brief Biography:

Dr. Mohit Kapoor completed his Bachelor’s degree in Pharmacy from theUniversityofPune(India) followed by double Masters degree in Pharmacology and Biotechnology from Sheffield University (UK). He then completed his PhD in Arthritis and Tissue Repair Research from the UniversityofOtago,New Zealand, followed by postdoctoral fellowships at the University of Kentucky (USA) and the UniversityofWestern Ontario(London,Canada). He is currently working as an Assistant Professor in the Department of Medicine at the University of Montreal, QC.

His research projects are funded by Canadian Institute of Health Research (CIHR),InstituteofMusculoskeletal Healthand Arthritis (IMHA), Canadian Foundation for Innovation (CFI), Canadian Arthritis Network, Fonds de Recherche SanteQuebec(FRSQ) and is a recipient of Young Investigator and bursary awards from Japan College of Rheumatology, ESCEO-AMGEN, International Osteoporosis Foundation and FRSQ. Dr. Kapoor is also a research investigator for the Canadian Scleroderma Research Group and Canadian Arthritis Network.

His research is directed towards identifying key novel mediators and signalling pathways involved in the pathophysiology of diseases including osteoarthritis, rheumatoid arthritis and scleroderma. His expertise includes generation of transgenic knock-out/knock-in mice (conditional cell/tissue-specific as well as whole body gene manipulation) to understand the complex pathophysiology of osteoarthritis, rheumatoid arthritis and scleroderma using animal models of disease and human disease specimens.

Academic positions:

Assistant Professor (Department of Medicine), University of Montreal.

Research interests:

My research is directed towards identifying key novel mediators and signalling pathways involved in the pathophysiology of diseases including osteoarthritis, rheumatoid arthritis and scleroderma. My expertise includes generation of transgenic knock-out/knock-in mice (conditional cell/tissue-specific as well as whole body gene manipulation) to understand the complex pathophysiology of osteoarthritis, rheumatoid arthritis and scleroderma using animal models of disease and human disease specimens.

What I think of the idea behind WebmedCentral:

Its a very innovative way of publishing research articles and I am sure this particular format is very practical in reaching larger audience.